Pulmonary Rehabilitation in Patients Recovering from COVID-19.


Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
2021
Historique:
received: 26 10 2020
accepted: 22 12 2020
pubmed: 31 3 2021
medline: 20 5 2021
entrez: 30 3 2021
Statut: ppublish

Résumé

In hospitalized patients recovering from the SARS-coronavirus-2 disease 19 (COVID-19), high prevalence of muscle weakness and physical performance impairment has been observed. The aim of this study was to evaluate the effectiveness of pulmonary rehabilitation in these subjects in a real-life setting. Retrospective data analysis of patients recovering from COVID-19, including those requiring assisted ventilation or oxygen therapy, consecutively admitted to an in-patient pulmonary rehabilitation program between April 1 and August 15, 2020. Short Physical Performance Battery (SPPB: primary outcome), Barthel Index (BI), and six-min walking distance were assessed as outcome measures. Data of 140 patients were analyzed. After rehabilitation, patients showed improvements in SPPB {from: (median [IQR]) 0.5 (0-7) to 7 (4-10), p < 0.001} and BI (from 55 [30-90] to 95 [65-100], p < 0.001), as well as in other assessed outcome measures. The proportion of patients unable at admission to stand, rise from a chair and walk was significantly reduced (p < 0.00). Pulmonary rehabilitation is possible and effective in patients recovering from COVID-19. Our findings may be useful to guide clinicians taking care of patients surviving COVID-19 infection.

Sections du résumé

BACKGROUND
In hospitalized patients recovering from the SARS-coronavirus-2 disease 19 (COVID-19), high prevalence of muscle weakness and physical performance impairment has been observed.
OBJECTIVES
The aim of this study was to evaluate the effectiveness of pulmonary rehabilitation in these subjects in a real-life setting.
METHODS
Retrospective data analysis of patients recovering from COVID-19, including those requiring assisted ventilation or oxygen therapy, consecutively admitted to an in-patient pulmonary rehabilitation program between April 1 and August 15, 2020. Short Physical Performance Battery (SPPB: primary outcome), Barthel Index (BI), and six-min walking distance were assessed as outcome measures.
RESULTS
Data of 140 patients were analyzed. After rehabilitation, patients showed improvements in SPPB {from: (median [IQR]) 0.5 (0-7) to 7 (4-10), p < 0.001} and BI (from 55 [30-90] to 95 [65-100], p < 0.001), as well as in other assessed outcome measures. The proportion of patients unable at admission to stand, rise from a chair and walk was significantly reduced (p < 0.00).
CONCLUSIONS
Pulmonary rehabilitation is possible and effective in patients recovering from COVID-19. Our findings may be useful to guide clinicians taking care of patients surviving COVID-19 infection.

Identifiants

pubmed: 33784696
pii: 000514387
doi: 10.1159/000514387
pmc: PMC8089404
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

416-422

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Elisabetta Zampogna (E)

Respiratory Rehabilitation of the Institute of Tradate, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.

Mara Paneroni (M)

Respiratory Rehabilitation of the Institute of Lumezzane, Istituti Clinici Scientifici Maugeri, IRCCS, Brescia, Italy.

Stefano Belli (S)

Respiratory Rehabilitation of the Institute of Veruno, Istituti Clinici Scientifici Maugeri, IRCCS, Veruno, Italy.

Maria Aliani (M)

Respiratory Rehabilitation of the Institute of Bari, Istituti Clinici Scientifici Maugeri, IRCCS, Bari, Italy.

Alessandra Gandolfo (A)

Respiratory Rehabilitation of the Institute of Pavia, Istituti Clinici Scientifici Maugeri, IRCCS, Pavia, Italy.

Dina Visca (D)

Respiratory Rehabilitation of the Institute of Tradate, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese-Como, Italy.

Maria Teresa Bellanti (MT)

Respiratory Rehabilitation of the Institute of Veruno, Istituti Clinici Scientifici Maugeri, IRCCS, Veruno, Italy.

Nicolino Ambrosino (N)

Respiratory Rehabilitation of the Institute of Montescano, Istituti Clinici Scientifici Maugeri, IRCCS, Montescano, Italy.

Michele Vitacca (M)

Respiratory Rehabilitation of the Institute of Lumezzane, Istituti Clinici Scientifici Maugeri, IRCCS, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH